Global and United States Melatonin Receptor Agonists Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global and United States Melatonin Receptor Agonists Market Report & Forecast 2024-2034
Melatonin receptor agonists, also known as melatonin agonists or melatonergic drugs, are a class of medications that bind and activate melatonin receptors in the brain. These receptors play a crucial role in regulating the sleep-wake cycle and circadian rhythms.
Market Analysis and InsightsGlobal and United States Melatonin Receptor Agonists Market
This report focuses on global and United States Melatonin Receptor Agonists market, also covers the segmentation data of other regions in regional level and county level.
The global Melatonin Receptor Agonists revenue was US$ 232 million in 2022 and is forecast to a readjusted size of US$ 451.7 million by 2034 with a CAGR of 10.0% during the forecast period (2024-2034).
The market for melatonin receptor agonists has witnessed growth in recent years due to the increasing recognition of the importance of sleep health and the rising prevalence of sleep disorders worldwide. Factors contributing to the market growth include lifestyle changes, stress-related sleep disturbances, shift work, and the growing elderly population, as sleep disorders tend to be more common in older adults.
Global Melatonin Receptor Agonists Scope and Market Size
Melatonin Receptor Agonists market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Melatonin Receptor Agonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2024-2034.
For United States market, this report focuses on the Melatonin Receptor Agonists market size by players, by Type and by Application, for the period 2024-2034. The key players include the global and local players, which play important roles in United States.
Takeda Pharmaceutical
Vanda Pharmaceuticals
Pfizer
Natrol
Pharmavite
Nature's Bounty
Jameison
Rexall Sundown
GNC
Xiu Zheng
Church & Dwight
BY-HEALTH
Solgar
Biotics Research
Now Food
Segment by Type
Ramelteon
Tasimelteon
Agomelatine
Other
Hospital
Clinic
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Melatonin Receptor Agonists definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Melatonin Receptor Agonists companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Melatonin Receptor Agonists in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Melatonin Receptor Agonists sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion
Market Analysis and InsightsGlobal and United States Melatonin Receptor Agonists Market
This report focuses on global and United States Melatonin Receptor Agonists market, also covers the segmentation data of other regions in regional level and county level.
The global Melatonin Receptor Agonists revenue was US$ 232 million in 2022 and is forecast to a readjusted size of US$ 451.7 million by 2034 with a CAGR of 10.0% during the forecast period (2024-2034).
The market for melatonin receptor agonists has witnessed growth in recent years due to the increasing recognition of the importance of sleep health and the rising prevalence of sleep disorders worldwide. Factors contributing to the market growth include lifestyle changes, stress-related sleep disturbances, shift work, and the growing elderly population, as sleep disorders tend to be more common in older adults.
Global Melatonin Receptor Agonists Scope and Market Size
Melatonin Receptor Agonists market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Melatonin Receptor Agonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2024-2034.
For United States market, this report focuses on the Melatonin Receptor Agonists market size by players, by Type and by Application, for the period 2024-2034. The key players include the global and local players, which play important roles in United States.
By Company
Takeda Pharmaceutical
Vanda Pharmaceuticals
Pfizer
Natrol
Pharmavite
Nature's Bounty
Jameison
Rexall Sundown
GNC
Xiu Zheng
Church & Dwight
BY-HEALTH
Solgar
Biotics Research
Now Food
Segment by Type
Ramelteon
Tasimelteon
Agomelatine
Other
Segment by Application
Hospital
Clinic
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Melatonin Receptor Agonists definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Melatonin Receptor Agonists companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Melatonin Receptor Agonists in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Melatonin Receptor Agonists sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices